Acute management of Afib/flutter with RVR for dummies
1. Are they hemodynamically stable?
--> no --> synchronized electrical cardioversion (unsync'd may cause the rhythm to degenerate into vfib). You proooooobably should call MICU or cards if you're gonna do this. You know the whole, coding-someone-by-yourself-is-a-bad-idea thing.
--> yes --> go to step 2.
2. Is there any evidence that organs are being underperfused?
--> yes --> be way more aggressive -- start with 5mg metop x3, and then go straight to esmolol gtt or dilt IV push x2 followed by dilt gtt if the BP Is good, or straight to amio load/gtt if BP Is not. Also, call for an ICU bed... few places allow this kind of thing to happen on the floor.
--> no --> can let people hang out -- start with 5mg metop pushes, or maybe even just PO drugs depending on how fast the rate is and how healthy they are.
which agent you pick depends on the BP and whether they have HF and what agents they are already on --> go to step 3/4/5
3. Is the blood pressure good?
--> yes --> b-blocker preferred, then CCB
--> no --> amio preferred, then dig (also give a bolus, unless HF)
4. Do they have horrible, decompensated HF?
--> yes --> dig preferred, then amio -- amio is way faster, but dig has inotropic effect... depends on how sick/fast they are vs how bad their HF is.
--> no --> beta blocker preferred, then CCB
5. Are they already on something?
--> yes --> increase the dose of that before you add additional agents. For example, if you're at 200mg/day of PO metop (50 q6) or 360 mg/day of PO dig (90 q6) and it's still not working, then add something else.
--> no --> select first agent based on below system:
Non heart failure patient with good blood pressure who isn't going that fast:
IV metop first, then if that fails add PO metop, then if that fails add PO dilt
Non heart failure patient with good blood pressure who is going fast:
IV metop first, then if that fails IV dilt push, then if that fails IV dilt gtt, if that fails then amio. If at any point, the BP starts to fail to tolerate all the drugs, switch to amio earlier.
Non heart failure patient with suboptimal blood pressure:
Fluid bolus first, if that fixes the BP then go with the above pathway, if that doesn't fix BP then go the below pathway.
Non heart failure patient with crappy blood pressure:
Fluid bolus then amio (IV load and gtt, or IV load and PO maintenance, depending on how fast they are and how urgently you need control). If that fails call MICU.
Decompensated heart failure patient who isn't going really fast and has OK kidneys:
Dig first, then if that fails, add amio.
Decomp heart failure, who is going fast and/or has bad kidneys:
Amio first, then if that fails, add dig (if kidneys are OK)
Also call cards... most of us probably shouldn't be managing afib/flutter with rvr in patients with decompensated heart failure...
About the options:
- IV Metop. Given as pushes of 5mg each, up to 3 times with a 5 minute wait between each one. It's fast, but there's no drip metop; so if it only transiently works then you have to switch to an agent that has a drip. If you think there's high chance of success that a few IV pushes of beta-blockade will make them better (i.e. you know the patient, metop has worked in the past, etc) then this is fine. Otherwise start with dilt or esmolol. Of note, the patient will need to go home on PO metoprolol and may need to remain on it indefinitely.
- PO metop. If IV metop works, then start a PO metop regimen - in b-blocker naive, start at 12.5 q6; can titrate up to 50q6. In a stable person who is not-that-fast and chillin' comfortably you can even just start with PO metop and titrate up as needed.
- Esmolol gtt: great drug, works really well, but not an option for non-ICU patients - half life 9-12 minutes means you need constant titration means there is no way the floor nurses will let you do this. In fact, even saying the word esmolol will cause the charge nurse to suddenly appear, bearing down on you with an angry expression, ready to bash your skull in with their ever-present clipboards. Try it. It's like a magic trick.
- IV dilt: Push 0.25mg/kg. Wait 15 minutes. If it didn't work, push 0.35 mg/kg. Wait 15 minutes. If that still doesn't work, start drip at 5-15mg/hr. Preferred drug for patients you don't know (may have atrial thrombus) and for people with tough to break a-fib who you think may need a drip.
- PO dilt: If you're gonna pick an agent to start, you're better off starting with PO beta-blockade than PO CCB esp in older people or people who you think might have suboptimal heart function (i.e. older, fat, HTN, DM, PAD, smoker, etc etc etc) -- CCB have more negative inotropy. If someone is already on dilt and it has worked for them you can keep pushing it up to 120q6.
- Amio: 150mg IV push, then 60mg/hr for 6 hours, then 30/hr for 12-18 hours depending on where you are. This is a great drug-- it works fast, it works well, it doesn't drop the BP (well, actually it does, but to a way smaller extent than CCB or BB), it doesn't have negative inotropy. The dangerous thing a is that it's a class III antiarrhythmic, and you can inadvertently cardiovert, and if they have an atrial thrombus you may cause an embolic stroke. Although you can inadvertently cardiovert with metop as well... this drug also has tons of long term side effects so its' not as a great of a choice for the long term, but if you're just trying to stabilize someone who is going fast and has terrible BP until someone who knows more about hearts than you comes along, its a fantastic choice.
- Dig: slow, but has positive inotropy. 1 hour onset time. At 6 hours, a significant number of people will still be tachycardic. Second line in heart failure patients who are unable to be rate controlled with amio. Don't use in people with renal failure!!
Monday, September 21, 2015
Friday, September 11, 2015
BP control and IPH recurrence
N=1145
Study type: semi-prospective cohort.
Years: 1994-2011
Inclusion criteria:
- Age > 18
- Supratentorial IPH
- Alive after 90 days
Exclusion criteria:
- IPH from vascular malformation/aneurysm, tumor, trauma, or hemorrhagic transformation of ischemic stroke
Methodology:
- Study was separated into lobar and non-lobar IPH
- Follow up was conducted at 3, 6, 9, 12 mos and every 6 mos thereafter - inquiring about death, evidence of ICH recurrence, recorded BPs, medications.
Outcome:
- Recurrence of IPH
Results
- Overall recurrence rate of lobar IPH was ~20% and of non-lobar was ~7%
Comment:
- In multivariate regression, use of antiplatelet assoc with significant increased risk of ICH; warfarin - trending - likely underpowered - but big hazard ratio
- In nonlobar ICH - the relationships between drugs and recurrent ICH is less clear - both in magnitude and in statistical significance. This might have to do with statistical power, as non-lobar was much less common.
Comment:
In case you've forgotten your JNC 7 guidelines
- Normotension: SBP <120 and DBP <80
- Prehypertension: SBP 120-140 or DBP 80-90
- Stage 1: SBP 140-160 or DBP 90-100
- Stage 2: SBP >160 or DBP > 100
note that normotension carries an "and" operator for SBP and DBP whereas the others carry an "or" operator
This is an incredible dose-response relationship between even mild HTN (ie >120) and recurrence; HR for just a SBP of 120-140 was 2.8 in lobar and 3.0 in non-lobar. Man.
JNC 8 recommended SBP goal of <150 (elevated from <140) in older adults (>60) without DM or CKD; the idea is that if you are too aggressive with your goal, you overshoot too low and old people have falls and leads to worse outcomes.
But perhaps in older adults with a history of IPH, we should be more aggressive...
N=1145
Study type: semi-prospective cohort.
Years: 1994-2011
Inclusion criteria:
- Age > 18
- Supratentorial IPH
- Alive after 90 days
Exclusion criteria:
- IPH from vascular malformation/aneurysm, tumor, trauma, or hemorrhagic transformation of ischemic stroke
Methodology:
- Study was separated into lobar and non-lobar IPH
- Follow up was conducted at 3, 6, 9, 12 mos and every 6 mos thereafter - inquiring about death, evidence of ICH recurrence, recorded BPs, medications.
Outcome:
- Recurrence of IPH
Results
- Overall recurrence rate of lobar IPH was ~20% and of non-lobar was ~7%
Comment:
- In multivariate regression, use of antiplatelet assoc with significant increased risk of ICH; warfarin - trending - likely underpowered - but big hazard ratio
- In nonlobar ICH - the relationships between drugs and recurrent ICH is less clear - both in magnitude and in statistical significance. This might have to do with statistical power, as non-lobar was much less common.
Comment:
In case you've forgotten your JNC 7 guidelines
- Normotension: SBP <120 and DBP <80
- Prehypertension: SBP 120-140 or DBP 80-90
- Stage 1: SBP 140-160 or DBP 90-100
- Stage 2: SBP >160 or DBP > 100
note that normotension carries an "and" operator for SBP and DBP whereas the others carry an "or" operator
This is an incredible dose-response relationship between even mild HTN (ie >120) and recurrence; HR for just a SBP of 120-140 was 2.8 in lobar and 3.0 in non-lobar. Man.
JNC 8 recommended SBP goal of <150 (elevated from <140) in older adults (>60) without DM or CKD; the idea is that if you are too aggressive with your goal, you overshoot too low and old people have falls and leads to worse outcomes.
But perhaps in older adults with a history of IPH, we should be more aggressive...
Thursday, September 10, 2015
PARKINSONS TREATMENTS
Supplements
- Vitamin E - not shown to have any benefit in a large trial
- Coenzyme Q10 - not shown to have any benefit in large trial
- Exercise - actually works
MAO-B inhibitors
- Selegiline - helps with some motor symptoms
- Rasagaline - may slightly slow progression of disease (ADAGIO trial)
- Rasagaline might be a little more effective than selegiline but its way more $$$
- This class of drugs is relatively ineffective but relatively benign; good to start with
- The whole wine-and-cheese tyramine thing is a bit oversold, you can probably eat tyramine containing food as long as you don't go overboard
Anticholinergics
- Triheyxyphenyldil (Artane): most effective for tremor. Causes urinary retention and all the other anticholinergic things. Causes significant confusion/cognitive fog -- which may be a dealbreaking side effect for people in school/taking classes, with jobs that take a lot of thinking, or in old people who are already pretty confused.
Dopamine Agonists
- Ropinirole (Requip)
- Pramipexole (Mirapex)
- Come in TID or extended release formulations (reallllly $$$)
- Rotigatine - patch - q24h
- Generally first-line in people under 65 - as they can delay the onset of dyskinesias. In people over 70, these drugs are both more likely to cause side effects (like confusion), and you're less worried about the progression of the disease over time.
- Side effects - Fatigue/somnolence, sleep attacks (seriously, people fall asleep at the wheel and get into accidents), nausea/vomiting, confusion, leg edema, postural hypotension, hallucinations
Sinemet
- Levodopa is the most effective drug we have in the management of symptoms - and most people will end up on it eventually
- Carbidopa is a DOPA decarboxylase inhibitor
- Levodopa crosses the BBB and is converted to dopamine in the blood - dopamine itself doesn't cross BBB. Carbidopa prevents conversion of levodopa to dopamine in periphery. Carbidopa also doesn't cross BBB.
- The old school "controlled release" sinemet (sinemet CR) was crappy - depended on acid degradation in the stomach, and on gastric transit and motility, so the blood levels fluctuated like crazy and were really unreliable. Sometimes now we use it at night, where it gives nighttime symptom relief or AM effects.
- There's a new extended release sinemet called Rytany that depends on differential sized beads and is much more reliable in terms of drug levels. Unfortunately its really, realllllly, realllllllllly expensive, and you have to take a lot of pills (ie like 3-4 pills TID or QID - the median is 3.6 times a day)
- However regular sinemet some people have to dose q2 hours, or q3 hours, which is just agonizing, and going from q2 to q5 or q6 dosing can be life-altering in a good way
COMT inhibitors
- Entacapone
- Tolcapone - more potent because better CNS penetration, but more reported cases of severe liver failure-possibly a fluke in early trials as the reported incidence is dropping with time; have to get monthly LFTs for the first 6 months
- In the late game, they decrease off time when given with sinemet
- Only given in combination with levidopa, not given alone-- they don't have much effect on their own. Also they result in disease with worse dyskinesias if given early, alone or in combo with sinemet.
Apomorphine
- Injection, subQ, need to premedicate with antiemetic, lasts 30-60 min, can bridge - i.e. take your sinemet and the injection and by the time injection wears off, pills have taken effect.
Duodopa
- gel delivered into the intestines, 89% rate of pump complications/malfunction/failure
DBS
- Usually can reduce the dose of meds, but still need meds
Treating Side Effects
Dyskinesias
- treatment: amantadine is very good for this. Doesn't affect PD itself.
- can decrease dose of sinemet
Freezing
- Can increase sinemet
Halluciinations
- stop Dopa agonist, MAOs, anticholinergics, amantadine
- decrease sinemet
- add seroquel
- add cholinesterase inhibitor
To be avoided in PD: anti dopamine drugs
- Neuroleptics - haldol, etc
- Antiemetics - promethazine, metoclopramide, etc
Supplements
- Vitamin E - not shown to have any benefit in a large trial
- Coenzyme Q10 - not shown to have any benefit in large trial
- Exercise - actually works
MAO-B inhibitors
- Selegiline - helps with some motor symptoms
- Rasagaline - may slightly slow progression of disease (ADAGIO trial)
- Rasagaline might be a little more effective than selegiline but its way more $$$
- This class of drugs is relatively ineffective but relatively benign; good to start with
- The whole wine-and-cheese tyramine thing is a bit oversold, you can probably eat tyramine containing food as long as you don't go overboard
Anticholinergics
- Triheyxyphenyldil (Artane): most effective for tremor. Causes urinary retention and all the other anticholinergic things. Causes significant confusion/cognitive fog -- which may be a dealbreaking side effect for people in school/taking classes, with jobs that take a lot of thinking, or in old people who are already pretty confused.
Dopamine Agonists
- Ropinirole (Requip)
- Pramipexole (Mirapex)
- Come in TID or extended release formulations (reallllly $$$)
- Rotigatine - patch - q24h
- Generally first-line in people under 65 - as they can delay the onset of dyskinesias. In people over 70, these drugs are both more likely to cause side effects (like confusion), and you're less worried about the progression of the disease over time.
- Side effects - Fatigue/somnolence, sleep attacks (seriously, people fall asleep at the wheel and get into accidents), nausea/vomiting, confusion, leg edema, postural hypotension, hallucinations
Sinemet
- Levodopa is the most effective drug we have in the management of symptoms - and most people will end up on it eventually
- Carbidopa is a DOPA decarboxylase inhibitor
- Levodopa crosses the BBB and is converted to dopamine in the blood - dopamine itself doesn't cross BBB. Carbidopa prevents conversion of levodopa to dopamine in periphery. Carbidopa also doesn't cross BBB.
- The old school "controlled release" sinemet (sinemet CR) was crappy - depended on acid degradation in the stomach, and on gastric transit and motility, so the blood levels fluctuated like crazy and were really unreliable. Sometimes now we use it at night, where it gives nighttime symptom relief or AM effects.
- There's a new extended release sinemet called Rytany that depends on differential sized beads and is much more reliable in terms of drug levels. Unfortunately its really, realllllly, realllllllllly expensive, and you have to take a lot of pills (ie like 3-4 pills TID or QID - the median is 3.6 times a day)
- However regular sinemet some people have to dose q2 hours, or q3 hours, which is just agonizing, and going from q2 to q5 or q6 dosing can be life-altering in a good way
COMT inhibitors
- Entacapone
- Tolcapone - more potent because better CNS penetration, but more reported cases of severe liver failure-possibly a fluke in early trials as the reported incidence is dropping with time; have to get monthly LFTs for the first 6 months
- In the late game, they decrease off time when given with sinemet
- Only given in combination with levidopa, not given alone-- they don't have much effect on their own. Also they result in disease with worse dyskinesias if given early, alone or in combo with sinemet.
Apomorphine
- Injection, subQ, need to premedicate with antiemetic, lasts 30-60 min, can bridge - i.e. take your sinemet and the injection and by the time injection wears off, pills have taken effect.
Duodopa
- gel delivered into the intestines, 89% rate of pump complications/malfunction/failure
DBS
- Usually can reduce the dose of meds, but still need meds
Treating Side Effects
Dyskinesias
- treatment: amantadine is very good for this. Doesn't affect PD itself.
- can decrease dose of sinemet
- Can increase sinemet
Halluciinations
- stop Dopa agonist, MAOs, anticholinergics, amantadine
- decrease sinemet
- add seroquel
- add cholinesterase inhibitor
To be avoided in PD: anti dopamine drugs
- Neuroleptics - haldol, etc
- Antiemetics - promethazine, metoclopramide, etc
Wednesday, September 9, 2015
Early data of the REVERSE-AD trial:
N=90, 184 sites, 35 countries
Study design: prospective cohort study;
Disclosures: funded by Boehringer Ingelhelm
Inclusion Criteria:
- People over the age of 18
- Group A: "Overt, uncontrollable or life-threatening bleeding that was judged by the treating clinician to require a reversal agent" (n=51; 18 ICH, 20 GIB, 9 trauma, 11 other)
- Group B: "Those who required surgery or other invasive procedures that could not be delayed for at least 8 hours an for which normal hemostasis was required" (n=39; Bone fractures 8 Acute cholecystitis 5 Acute renal insufficiency, catheter placement 4 Acute appendicitis 3 Joint/wound infection 3 Abscess (suprapubic, scrotal) 2 .... no neurosurgical procedures)
Primary endpoint:
- Maximum % reversal of dabigatran as determined by dilute thrombin time or ecarin clotting time measurements
Secondary endpoints:
- proportion of patients with complete normalization of dilute thrombin time or ecarin clotting time in first 4 hours
- Reduction in concentration of unbound dabigatran in the blood.
- Group A: Severity of bleeding (by scales - ISTH, GUSTO, modified rankin)
- Group B: h"hemostasis during the intervention was classified by the physician as normal, or as mildly, moderately, or severely abnormal"
Results:
- Of the 18 people with ICH, time to cessation of bleeding could not be ascertained in 5. Overall, the time to cessation of bleeding could not be ascertained in 13 of 51.
- Of the remaining 33, "the median investigator reported time to the cessation of bleeding was 11.4 hours"
Group B
- "normal intraoperative hemostasis was reported in 33 of 36"
Thrombotic Events:
- 5 out of 90 people
- DVT x 3, PE x2, stroke x1, NSTEMI x1
Interesting sidepoint for neurosurgeons
- "the proportion of patients with intracranial bleeding was higher among the 11 patients who had normal results on the clotting tests at baseline than among the 40 who had elevated results at baseline"
- So basically, the people who were LESS anticoagulated had more head bleeds.....
Comments:
- Clinical endpoints are terrible - what the heck does "the median investigator reported time to the cessation of bleeding was 11.4 hours" even mean? Who is making this call? And by what metric? Is that by CT? Exam? Only 1/3 of the cases were cranial -- it was a potpourri of etiologies. Also, if the reversal happened immediately, why did it take 11 hours to stop bleeding? Is this just people getting a follow up CT scan 6 or 12 or 24 hours afterwards and seeing stability?
- No neurosurgical cases in the B group.
- Non-randomized, non-blinded, no control group
N=90, 184 sites, 35 countries
Study design: prospective cohort study;
Disclosures: funded by Boehringer Ingelhelm
Inclusion Criteria:
- People over the age of 18
- Group A: "Overt, uncontrollable or life-threatening bleeding that was judged by the treating clinician to require a reversal agent" (n=51; 18 ICH, 20 GIB, 9 trauma, 11 other)
- Group B: "Those who required surgery or other invasive procedures that could not be delayed for at least 8 hours an for which normal hemostasis was required" (n=39; Bone fractures 8 Acute cholecystitis 5 Acute renal insufficiency, catheter placement 4 Acute appendicitis 3 Joint/wound infection 3 Abscess (suprapubic, scrotal) 2 .... no neurosurgical procedures)
Primary endpoint:
- Maximum % reversal of dabigatran as determined by dilute thrombin time or ecarin clotting time measurements
Secondary endpoints:
- proportion of patients with complete normalization of dilute thrombin time or ecarin clotting time in first 4 hours
- Reduction in concentration of unbound dabigatran in the blood.
- Group A: Severity of bleeding (by scales - ISTH, GUSTO, modified rankin)
- Group B: h"hemostasis during the intervention was classified by the physician as normal, or as mildly, moderately, or severely abnormal"
Results:
All of the figures basically look like this, where the lab values immediately normalize after administration of the sample
Clinical results?
Group A- Of the 18 people with ICH, time to cessation of bleeding could not be ascertained in 5. Overall, the time to cessation of bleeding could not be ascertained in 13 of 51.
- Of the remaining 33, "the median investigator reported time to the cessation of bleeding was 11.4 hours"
Group B
- "normal intraoperative hemostasis was reported in 33 of 36"
Thrombotic Events:
- 5 out of 90 people
- DVT x 3, PE x2, stroke x1, NSTEMI x1
Interesting sidepoint for neurosurgeons
- "the proportion of patients with intracranial bleeding was higher among the 11 patients who had normal results on the clotting tests at baseline than among the 40 who had elevated results at baseline"
- So basically, the people who were LESS anticoagulated had more head bleeds.....
Comments:
- Clinical endpoints are terrible - what the heck does "the median investigator reported time to the cessation of bleeding was 11.4 hours" even mean? Who is making this call? And by what metric? Is that by CT? Exam? Only 1/3 of the cases were cranial -- it was a potpourri of etiologies. Also, if the reversal happened immediately, why did it take 11 hours to stop bleeding? Is this just people getting a follow up CT scan 6 or 12 or 24 hours afterwards and seeing stability?
- No neurosurgical cases in the B group.
- Non-randomized, non-blinded, no control group
Subscribe to:
Posts (Atom)